Clinical trials for prion disease: difficult challenges, but hope for the future

The Lancet Neurology

Volumn 8, Issue 4, 2009, Pages 304-306

  Geschwind, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; FLUPIRTINE; MEPACRINE; PENICILLIN G;

CLINICAL TRIAL; CREUTZFELDT JAKOB DISEASE; DISEASE SEVERITY; DRUG EFFECT; HUMAN; HYPOMANIA; LETTER; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

AMINOPYRIDINES; CLINICAL TRIALS AS TOPIC; HUMANS; PRION DISEASES; QUINACRINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 62549158694     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70050-X     Document Type: Letter

References (11)

1. Prusiner S.B. Shattuck lecture-neurodegenerative diseases and prions. N Engl J Med 344 (2001) 1516-1526
2. Trevitt C.R., and Collinge J. A systematic review of prion therapeutics in experimental models. Brain 129 (2006) 2241-2265
3. Bone I. Intraventricular pentosan polysulfate in human prion diseases. A study of experience in the United Kingdom. In: Unit UKCS, ed. Edinburgh, UK, 2006: 1-11.
4. Korth C., May B.C.H., Cohen F.E., and Prusiner S.B. Acridine and phenothiazine derivatives as pharmacoptherapeutics for prion disease. Proc Natl Acad Sci USA 98 (2001) 9836-9841
5. Otto M., Cepek L., Ratzka P., et al. Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study. Neurology 62 (2004) 714-718
6. Collinge J., Gorham M., Hudson F., et al. Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Lancet Neurol 8 (2009) 334-344
7. Engel G.L. Quinacrine effects on the central nervous system. JAMA 197 (1966) 505
8. Haik S., Brandel J.P., Salomon D., et al. Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects. Neurology 63 (2004) 2413-2415
9. Nakajima M., Yamada T., Kusuhara T., et al. Results of quinacrine administration to patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 17 (2004) 158-163
10. CJD (Creutzfeldt-Jakob disease) quinacrine study. http://clinicaltrials.gov/ct2/show/NCT00183092 (accessed March 4, 2009).
11. Kennedy A., Walker S., Thomas D., Rossor M., Darbyshire J., and Collinge J. Quinacrine in possible or probable CJD. BMJ 324 (2002) 239